Cases 1 - 5 of 5
In re: MDL 2700 Genentech
as 19-5035
Plaintiff / Appellant:
TENNESSEE ONCOLOGY, PLLC, a Tennessee Professional Limited Liability Corporation, FLORIDA CANCER SPECIALISTS, P.L., a Florida Professional Limited Liability, VIRGINIA CANCER INSTITUTE, a Virginia Commonwealth Professional Corporation and others
Defendant:
ROCHE HOLDING LTD., ROCHE HOLDINGS, INC. and ROCHE HOLDING AG
Defendant / Appellee:
GENENTECH, INC., a California Corporation
Hematology-Oncology Associates of Central New York, P.C. v. Genentech Inc.. ***ALL FILINGS in this member case must also be made in the MDL master case 16-md-2700.***
as 4:2016cv00221
Plaintiff:
Hematology-Oncology Associates of Central New York, P.C.
Defendant:
Genentech Inc.
Cause Of Action: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
In Re: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation ***ALL FILINGS in this MDL master case must also be made in the affected individual member cases.***
as 4:2016md02700
Plaintiff:
Tulsa Cancer Institute, PLLC , Oklahoma Oncology & Hematology, Inc. , State of Oklahoma and others
Defendant:
Genentech, Inc.
Cause Of Action: No cause code entered
Hematology-Oncology Associates of Central New York, P.C. v. Genentech Inc.
as NYN/5:16-cv-00121
Plaintiff:
Hematology-Oncology Associates of Central New York, P.C.
Defendant:
Genentech Inc.
Hematology-Oncology Associates of Central New York, P.C. v. Genentech Inc.
as 5:2016cv00121
Plaintiff:
Hematology-Oncology Associates of Central New York, P.C.
Defendant:
Genentech Inc.
Cause Of Action: 28 U.S.C. ยง 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
